SMITH, ERNEST S.,ZAUDERER, MAURICE,BOWERS, WILLIAM J.,JONASON, ALAN
申请号：
PL14855074
公开号：
PL3060252T3
申请日:
2014.10.21
申请国别(地区):
PL
年份:
2020
代理人:
摘要：
Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors.
